The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vostrikov V.V.

Altai State Medical University;
Siberian Institute of Human Reproduction and Genetics

Zdanovsky V.M.

Professor V.M. Zdanovsky Clinic

Subbotin E.A.

Altai State Medical University

Reproductive function in patients with signs of polycystic ovary syndrome

Authors:

Vostrikov V.V., Zdanovsky V.M., Subbotin E.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2025;31(6): 60‑69

Read: 255 times


To cite this article:

Vostrikov VV, Zdanovsky VM, Subbotin EA. Reproductive function in patients with signs of polycystic ovary syndrome. Russian Journal of Human Reproduction. 2025;31(6):60‑69. (In Russ.)
https://doi.org/10.17116/repro20253106160

Recommended articles:
Medi­cal and social characteristics of mate­rnal deaths after extracorporeal fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):5-14

References:

  1. Nazarenko TA. E`ndokrinny`e faktory` zhenskogo i muzhskogo besplodiya. M.: Medicinskoe informacionnoe agentstvo; 2017. (In Russ.).
  2. Nazarenko TA. Sindrom polikistozny`x yaichnikov. M.: MEDpress-inform; 2008. (In Russ.).
  3. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility. 2016;106(1):6-15.  https://doi.org/10.1016/j.fertnstert.2016.05.003
  4. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2016; 31:2841-2855. https://doi.org/10.1093/humrep/dew218
  5. Manro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM. The FIGO Ovulatory Disorders Classification System. Russian Journal of Human Reproduction. 2023;29(1):116-136. (In Russ.). https://doi.org/10.17116/repro202329011116
  6. Lizneva D, Kirubakaran R, Mykhalchenko K, Suturina L, Chernukha G, Diamond MP, Azziz R. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertility and Sterility. 2016;106:1510-1520. https://doi.org/10.1016/j.fertnstert.2016.07.1121
  7. Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertility and Sterility. 2010;94(6):2197-201.  https://doi.org/10.1016/j.fertnstert.2010.02.014
  8. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. The Journal of Clinical Endocrinology and Metabolism 2006;91:781-785.  https://doi.org/10.1210/jc.2005-2153
  9. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction. 2018;33:1602-1618. https://doi.org/10.1093/humrep/dey256
  10. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen O.E, Legro RS, Norman RJ, Taylor AE, Witchel SF. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology and Metabolism. 2006;91(Issue 11):4237-4245. https://doi.org/10.1210/jc.2006-0178
  11. Fertility: Assessment and Treatment for People with Fertility Problems. National Collaborating Centre for Women’s and Children’s Health (UK). London; 2013. Accessed October 11, 2025. https://pubmed.ncb.nlm.gov
  12. Zhenskoye besplodiye. Klinicheskie rekomendatsii. 2021. Accessed October 11, 2025. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_388620/8efd5f17af55cb35a770f73937590c642437b7eb/
  13. Truxachyova NV. Matematicheskaya statistika v mediko-biologicheskikh issledovaniyakh. M.: GEHOTAR-Media. (In Russ.).
  14. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19(1):41-47.  https://doi.org/10.1093/humrep/deh098
  15. Prior JC, Naess M, Langhammer A, Forsmo S Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles — A Population-Based Cohort from HUNT3, Norway. PLoS One.2015;10(8):e0134473. https://doi.org/10.1371/journal.pone.0134473
  16. World Health Organization. Adherence to long-term therapies: evidence for action. WHO Library Cataloguing-in-Publication Data. Geneva: WHO; 2003.
  17. Lukina YuV, Kutishenko NP, Martsevich SYu. Adherence to Treatment: A Modern Perspective on a Familiar Issue. Kardiovaskulyarnaya terapiya i profilaktika. 2017;16(1):91-95.  https://doi.org/10.15829/1728-8800-2017-1-91-95
  18. National Institute for Health and Care Excellence (NICE). Fertility problems: Assessment and treatment. Clinical guideline CG156.: NICE and RCOG; 2013.
  19. WHO-Scientific-Group. Agents stimulating gonadal function in the human. Report of a WHO scientific group. World Health Organization Technical Report Series. 1973;514:1-30. 
  20. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. The Journal of Clinical Endocrinology and Metabolism. 2006;91:786-789.  https://doi.org/10.1210/jc.2005-2501
  21. Mumusoglu S, Yildiz BO. Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population. Current Opinion in Endocrine and Metabolic Research. 2020;12:66-71.  https://doi.org/10.1016/j.coemr.2020.03.004
  22. Rosenfield RL. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. Journal of Pediatric and Adolescent Gynecology. 2015;28(6):412-419.  https://doi.org/10.1016/j.jpag.2014.07.016
  23. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O’Keefe M, Ghazzi MN. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2001;86(4):7375. https://doi.org/1626-1632.10.1210/jcem.86.4.7375
  24. Awoke MA, Earnest A, Joham AE, Hodge AM, Teede HJ, Brown WJ, Moran LJ. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Human Reproduction. 2022;37(1):129-141.  https://doi.org/10.1093/humrep/deab239
  25. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. International Journal of Women’s Health. 2011;3:25.  https://doi.org/10.2147/IJWH.S11304
  26. Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Human Reproduction Update. 2016; 22: 687-708.  https://doi.org/10.1093/humupd/dmw025
  27. Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Human Reproduction. 2017;32: 261-264.  https://doi.org/10.1093/humrep/dew287
  28. Lawrenz B, Melado L, Fatemi HM. Countercurrent Ovulation induction in anovulatory infertility is obsolete. Reproductive BioMedicine Online. 2022;8:1472-6483. https://doi.org/10.1016/j.rbmo.2022.08.102
  29. Allahbadia GN. Intrauterine Insemination: Fundamentals Revisited. The Journal of Obstetrics and Gynecology of India. 2017;67(6):385-392.  https://doi.org/10.1007/s13224-017-1060-x
  30. Sindrom polikistoznyh yaichnikov. Klinicheskie rekomendacii. 2021. Accessed October 11, 2025. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_390453/8efd5f17af55cb35a770f73937590c642437b7eb/
  31. Roy Homburg, Clomiphene citrate—end of an era? a mini-review. Human Reproduction. 2005;20:2043–2051. https://doi.org/10.1093/humrep/dei042

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.